The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Tavaborole
Tavaborole · TAVABOROLE 43.5 mg/mL · Solution · Topical · Alembic Pharmaceuticals Limited
NDC 46708-0467-04 · 1 BOTTLE, DROPPER in 1 CARTON / 4 mL in 1 BOTTLE, DROPPER · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for tavaborole (other) in the next 90 days
sole-source market · 1 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA212188
- TE code
- AB
- Approval date
- Oct 21, 2020
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Tavaborole (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Alembic Pharmaceuticals Inc. | TAVABOROLE 43.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | TAVABOROLE 43.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals NY LLC | TAVABOROLE 43.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | TAVABOROLE 43.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Cipla USA Inc. | TAVABOROLE 43.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Viona Pharmaceuticals Inc | TAVABOROLE 43.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Zydus Lifesciences Limited | TAVABOROLE 43.5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Tavaborole — NDC 46708-0467-04," retrieved September 3, 2026, https://drugdashboards.com/drug/46708046704.
Free to cite with attribution — see how the data is put together.